Update on Ocular Myasthenia Gravis

Semin Neurol. 2019 Dec;39(6):749-760. doi: 10.1055/s-0039-1700527. Epub 2019 Dec 17.

Abstract

Myasthenia gravis is an antibody-mediated autoimmune disorder of the post-synaptic neuromuscular junction resulting in fluctuating, fatigable weakness. Most patients first present with extraocular symptoms (diplopia and/or ptosis), and in 15% of cases symptoms will remain restricted to only the extraocular muscles (ocular myasthenia gravis [OMG]). The history and clinical examination are of the utmost importance in correctly identifying OMG patients, as supportive serologic or electrodiagnostic studies are frequently nondiagnostic. In this review, we outline a diagnostic approach to OMG (focusing on key clinical features), discuss therapeutic options, and highlight recent developments in the understanding of OMG.

Publication types

  • Review

MeSH terms

  • Humans
  • Myasthenia Gravis / diagnosis*
  • Myasthenia Gravis / therapy*